Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kent Athlone Pharma Group (KAPG) is a leading specialty pharmaceutical company focused on the development, manufacture, and distribution of generic medicines across the UK, Ireland, and international markets. Formed through the integration of Kent Pharma and Athlone Pharma, the group maintains a diverse portfolio of over 500 products, with a particular strength in beta-lactam antibiotics and specialty injectables. The company operates a dedicated manufacturing facility in Ireland and provides contract manufacturing services alongside its own product commercialization. KAPG serves a broad range of healthcare providers, including hospitals, wholesalers, and pharmacies, positioning itself as a critical supplier in the European generic pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kent Athalone Pharma Group.